ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Unbilled Receivables
ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Unbilled Receivables of -$433.00 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2018-11-29.
Discontinued › Notes › Revenue Recognition and Deferred Revenue
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2018-11-29
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for the quarter ending 2016-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for the quarter ending 2016-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for the quarter ending 2016-03-31 was -$1.01M.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for the quarter ending 2015-12-31 was $576.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for fiscal 2016 was -$433.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for fiscal 2015 was -$2.34M, a 217.67% decline from fiscal 2014.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for fiscal 2014 was $1.99M.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in unbilled receivables for fiscal 2013 was -$1.11M, a 158.58% decline from fiscal 2012.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $0.00 derived: sum of 2 quarters · filed 2018-11-29 | -$1.01M derived: sum of 3 quarters · filed 2018-11-29 | -$433.00K 10-K · filed 2018-11-29 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$1.01M derived: sum of 2 quarters · filed 2017-08-09 | -$433.00K 10-Q · filed 2017-08-09 | -$1.38M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$433.00K 10-Q · filed 2017-05-10 | -$1.38M derived: sum of 3 quarters · filed 2017-12-11 | -$1.55M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $576.00K 10-Q · filed 2017-02-09 | -$367.00K derived: sum of 2 quarters · filed 2017-12-11 | -$541.00K derived: sum of 3 quarters · filed 2017-12-11 | -$873.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | -$943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | -$1.12M derived: sum of 2 quarters · filed 2017-12-11 | -$1.45M derived: sum of 3 quarters · filed 2017-12-11 | -$2.34M 10-K · filed 2017-12-11 |
| 2015-06-30 | -$174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$506.00K derived: sum of 2 quarters · filed 2016-08-09 | -$1.39M 10-Q · filed 2016-08-09 | -$883.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | -$332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | -$1.22M 10-Q · filed 2016-05-10 | -$709.00K derived: sum of 3 quarters · filed 2016-12-09 | -$54.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | -$888.00K 10-Q · filed 2016-02-09 | -$377.00K derived: sum of 2 quarters · filed 2016-12-09 | $278.00K derived: sum of 3 quarters · filed 2016-12-09 | $953.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $1.17M derived: sum of 2 quarters · filed 2016-12-09 | $1.84M derived: sum of 3 quarters · filed 2016-12-09 | $1.99M 10-K · filed 2016-12-09 |
| 2014-06-30 | $655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | $1.33M derived: sum of 2 quarters · filed 2015-08-10 | $1.48M 10-Q · filed 2015-08-10 | $1.28M derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $675.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $820.00K 10-Q · filed 2015-05-08 | $623.00K derived: sum of 3 quarters · filed 2015-12-11 | $836.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $145.00K 10-Q · filed 2015-02-06 | -$52.00K derived: sum of 2 quarters · filed 2015-12-11 | $161.00K derived: sum of 3 quarters · filed 2015-12-11 | $386.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | -$197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $16.00K derived: sum of 2 quarters · filed 2015-12-11 | $241.00K derived: sum of 3 quarters · filed 2015-12-11 | -$1.11M 10-K · filed 2015-12-11 |
| 2013-06-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $438.00K derived: sum of 2 quarters · filed 2014-08-12 | -$912.00K 10-Q · filed 2014-08-12 | -$535.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | -$1.13M 10-Q · filed 2014-05-12 | -$748.00K derived: sum of 3 quarters · filed 2014-12-11 | -$474.00K derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | -$1.35M 10-Q · filed 2014-02-13 | -$973.00K derived: sum of 2 quarters · filed 2014-12-11 | -$699.00K derived: sum of 3 quarters · filed 2014-12-11 | |
| 2012-09-30 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $651.00K derived: sum of 2 quarters · filed 2014-12-11 | $1.89M 10-K · filed 2014-12-11 | |
| 2012-06-30 | $274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $1.52M 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $1.24M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |